Approval is
granted for the grantee-Level Instrument, but not for the
client-level data collection tools.
Inventory as of this Action
Requested
Previously Approved
06/30/2022
36 Months From Approved
1,436
0
0
244
0
0
0
0
0
There will be up to 359 award
recipients (states, territories, and tribal entities) in these
grant programs. Grantee-level data will include information related
to naloxone purchases and distribution. This grantee-level
information will be collected quarterly. All funded
states/territories and tribal entities will also be required to
collect and report client-level data on individuals who are
receiving opioid treatment services to ensure program goals and
objectives are being met. Client-level data will include
information such as: demographic information, services
planned/received, mental health/substance use disorder diagnoses,
medical status, employment status, substance use, legal status, and
psychiatric status/symptoms. Client level data will be collected at
intake/baseline, three months post intake, six months post intake,
and at discharge.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.